From cytogenetics to cytogenomics of tumors;De la cytogenetique a la cytogenomique oncologique

Medecine/Sciences

Volumn 16, Issue 4, 2000, Pages 528-539

  Bernheim, Alain ^a   Vagner Capodano, Anne Marie ^b   Couturier, Jérôme ^c  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b TIMONE HOSPITAL   (France)

^c INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CYTOGENETICS; EWING SARCOMA; FUSION GENE; GENE AMPLIFICATION; GENETICS; GENOTYPE; HUMAN; METAPHASE; METASTASIS; NEUROECTODERM TUMOR; ONCOGENE; PROGNOSIS; RELAPSE; REVIEW; RHABDOMYOSARCOMA; SARCOMA; TUMOR SUPPRESSOR GENE;

EID: 0034093612     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/1686     Document Type: Review

References (37)

1. Mitelman F. Catalog of chromosome aberrations in cancer. CD-ROM. Version 1. New York: Wiley-Liss, 1998.
2. Atlas of genetics and cytogenetics in oncology and haematology. http://www. iufobiogen.fr/services/chromcancer/.
3. CGH analyses of primary human tumors. http://www.nhgri.nih.goy/DIR/LCG/CGH.
4. ISCN. An international system for human cytogenetic nomenclature. In: Mitelman F, ed. Basel: Karger, 1995.
5. Speicher MR, Gwyn Ballard S, Ward DC. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 1996; 12: 368-75.
6. Zattara-Cannoni H, Dufour H, Lepidi H, et al. Hidden chromosome abnormalities in a primary central nervous system lymphoma detected by multicolor spectral karyotyping. Cancer Genet Cytogenet 1998; 107: 98-101.
7. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258: 818-21.
8. Forozan F, Karhu R, Kononen J, et al. Genome screening by comparative genomic hybridization. Trends Genet 1997; 13: 405-9.
9. Vaandrager JW, Schuuring E, Kluin-Nelemans HC, et al. DNA fiber fluorescence in situ hybridization analysis of immunoglobulin class switching in B-cell neoplasia: aberrant CH gene rearrangements in follicle center-cell lymphoma. Blood 1998; 92: 2871-8.
10. Pollack JR, Perou CM, Alizadeh AA, et al. Genome-wide analysis of DNA copy number changes using cDNA microarrays. Nat Genet 1999; 23: 41-6.
11. Mitelman F, Mertens F, Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 1997; numéro spécial: 417-74.
12. Sreekantaiah C. The cytogenetic and molecular characterization of benign and malignant soft tissue tumors. Cytogenet Cell Genet 1998; 82: 13-29.
13. Delattre O, Zucman J, Melot T, et al. The Ewing family of tumors: a subgroup of small round cell tumors defined by specific chimeric transcripts. N Engl J Med 1994; 31: 294-9.
14. Hollingsworth RE, Lee WH. Tumor suppressor genes: new prospects for cancer research. J Natl Cancer Inst 1991; 83: 91-6.
15. Cowell JK, Hogg A. Genetics and cytogenetics of retinoblastoma. Cancer Genet Cytogenet 1992; 64: 1-11.
16. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68: 820-3.
17. Rousseau-Merck MF, Versteege I, Legrand I, et al. HSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors. Cancer Res 1999; 59: 3152-6.
18. Coquelle A, Pipiras E, Toledo F, et al. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 1997; 89: 215-25.
19. Knuutila S, Bjorkqvist AM, Autio K, et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 1998; 152: 1107-23.
20. Révillion K, Bonneterre J, Peyrat J. ERBB2 Oncogene in human breast cancer and its clinical significance. Eur J Cancer 1998; 34: 791-808.
21. Couturier J, Vincent-Salomon A, Nicolas A, et al. Strong correlation between fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER2-neu) gene status in breast carcinoma. Mol Pathol 2000 (sous presse).
22. Pegram M, Lipton A, Hayes D, et al. Phase II study of receptor enhanced chemosensitivity using recombination humanized anti-p185HER/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. J Clin Oncol 1998; 16: 2659-71.
23. Zankl H, Zang KD. Correlation between clinical and cytogenetical data in 180 meningiomas. Cancer Genet Cytogenet 1980; 1: 346-51.
24. Zattara-Cannoni H, Gambarelli H, Dufour D, et al. Contribution of cytogenetics and FISH in the diagnosis of meningiomas. A study of 189 tumours. Ann Genet 1998; 41: 164-5.
25. Weber RG, Boström J, Wolter M, et al. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 1997; 94: 14719-24.
26. Shimada H, Ambros IM, Dehner LP, et al. The international neuroblastoma pathology classification. Cancer 1999; 86: 364-72.
27. Brodeur GM, Fong C. Molecular biology and genetics of human neuroblasloma. Cancer Genet Cytogenet 1989; 41: 153-74.
28. Reiter JL, Brodeur GM. MYCM is the only highly expressed gene from the core amplified domain in human neuroblastomas. Genes Chromosomes Cancer 1998; 23: 134-40.
29. Meddeb M, Danglot G, Chudoba I, et al. Additional copies of a 25-Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomas. Gene Chromosomes Cancer 1996; 17: 156-65.
30. Bown N, Cotterill S, Lastowska M, et al. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med 1999; 340: 1954-61.
31. van den Berg E, Dijkhuisen T, Oosterhuis JW, et al. Cytogenetic classification of renal cancer. Cancer Genet Cytogenet 1997; 95: 103-7.
32. Glukhova L, Goguel AF, Chudoba I, et al. Overrepresentation of 7q31 and 17q in renal cell carcinomas. Genes Chrom Cancer 1998; 22: 171-8.
33. Schmidt L, Junker K, Nakaigawa N, et al. Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene 1999; 18: 2343-50.
34. Dijkhuisen T, van den Berg E, Störkel S, et al. Distinct features lor chromiphilic renal cell cancer with Xp11.2 breakpoints. Cancer Genet Cytogenet 1998; 104: 74-6.
35. Pérot C, Bougaran J, Boccon-Gibod L, et al. Two new cases of papillary renal cell carcinoma with t(X;1) (p11;q21) in females. Cancer Genet Cytogenet 1999; 110: 54-6.
36. nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 1997; 15: 2233-9.
37. Hahn WC, Couter CM, Lundberg AS, et al. Creation of human tumour cells with defined genetic elements. Nature 1999; 400: 464-8.